✦ LIBER ✦

High-Dose Carmustine, Etoposide, and Cyclophosphamide Followed by Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma

✍ Scribed by Lisa Y. Law; Sandra J. Horning; Ruby M. Wong; Laura J. Johnston; Ginna G. Laport; Robert Lowsky; Judith A. Shizuru; Karl G. Blume; Robert S. Negrin; Keith E. Stockerl-Goldstein

Book ID: 116279003
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 178 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.02.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive conditioning regimen of etopos

Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma

✍ Benekli, M; Smiley, S L; Younis, T; Czuczman, M S; Hernandez-Ilizaliturri, F; Ba 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 175 KB

High dose cyclophosphamide, etoposide an

High dose cyclophosphamide, etoposide and carmustine and peripheral stem cell transplantation for patients with relapsed hodgkin disease and bone marrow abnormalities

✍ Anne Kessinger; Julie M. Vose; Philip J. Bierman; James O. Armitage 📂 Article 📅 1992 🏛 AlphaMed Press 🌐 English ⚖ 134 KB

High-dose cyclophosphamide, BCNU, and VP

High-dose cyclophosphamide, BCNU, and VP-16 (CBV) conditioning before allogeneic stem cell transplantation for patients with non-Hodgkin's lymphoma

✍ Rossi, H A; Becker, P S; Emmons, R V B; Westervelt, P; Levy, W; Liu, Q; Clark, Y 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

Dose-Intense Cyclophosphamide and Etopos

Dose-Intense Cyclophosphamide and Etoposide for Patients with Refractory or High-Risk Non-Hodgkin's Lymphoma

✍ Talbot, Jeffrey; Ibom, Valerie K.; Rizzieri, David A.; Barrier, Robert; Niedzwie 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 153 KB

Augmented high dose cyclophosphamide, et

Augmented high dose cyclophosphamide, etoposide, and carmustine followed by transplantation with peripheral blood stem cells (PBSC) in the treatment of relapsed or refractory Hodgkin’s disease

✍ J.E. Schwartz; M.J. Robertson; K.G. Cornetta; L.D. Cripe; R.P. Nelson; C.T. Yian 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 76 KB

High dose salvage therapy with dose inte

High dose salvage therapy with dose intensive cyclophosphamide, etoposide and cisplatin may increase transplant rates for relapsed/refractory aggressive non-Hodgkin lymphoma

✍ Vijay, Archana; Duan, Qiuli; Henning, Jan-Willem; Duggan, Peter; Daly, Andrew; S 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 246 KB